Chromatin biomarkers reveal the fingerprints of cancer-associated secretomes isolated by a micropillar-guided platform
Open Access
- 29 June 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Current liquid-biopsy technologies predominantly rely on genomic and proteomic analyses to detect tumor-derived signals in blood. However, the extremely low abundance of tumor secretome components remains a major limitation for reliable detection. Here, we introduce an AI-driven imaging framework that leverages chromatin-based cellular fingerprints as functional biosensors to detect cancer-associated blood-derived secretome signals. As a proof of concept, we demonstrate that human stromal fibroblasts exhibit a higher signal-to-noise ratio for detecting prostate cancer-derived secretomes isolated from whole blood compared with immune cells. Notably, aged fibroblasts display enhanced sensitivity relative to their young counterparts and T cells. To achieve a fully integrated sample-to-sensing workflow, we combined this imaging approach with a micropillar-guided secretome/plasma isolation platform coupled to an on-chip cell-culture chamber, enabling rapid exposure of sensor cells to tumor-derived secretome factors. Together, our results establish a proof-of-concept exploratory study demonstrating the feasibility of chromatin-based functional biosensing of cancer-associated blood-derived secretome signals.Keywords
Funding Information
- PSI - Paul Scherrer Institute
This publication has 52 references indexed in Scilit:
- A microfluidic device to separate high-quality plasma from undiluted whole blood sample using an enhanced gravitational sedimentation mechanismAnalytica Chimica Acta, 2022
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2022
- Multiple Reaction Monitoring-Mass Spectrometry Enables Robust Quantitation of Plasma Proteins Regardless of Whole Blood Processing Delays That May Occur in the ClinicMolecular & Cellular Proteomics, 2022
- Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespanNeuroImage, 2020
- Regulation of genome organization and gene expression by nuclear mechanotransductionNature Reviews Molecular Cell Biology, 2017
- A microfluidic device for label-free, physical capture of circulating tumor cell clustersNature Methods, 2015
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer MetastasisCell, 2014
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblastsNature Cell Biology, 2013
- Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of diseaseNature Biotechnology, 2012
- Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteinsDrug Discovery Today, 2008